Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Director's Dealing

2 Aug 2024 09:44

RNS Number : 9860Y
Steppe Cement Limited
02 August 2024
 

2 August 2024

Steppe Cement Limited

("Steppe Cement" or the "Company")

Director's Dealing

Steppe Cement Limited announces that is has been notified that the family of the Company's Chief Executive Officer, Javier del Ser Pérez, has purchased 125,000 ordinary shares of nil par value each in the capital of the Company ("Ordinary Shares"), at a price of 13.42 pence per share, via Portola Group Limited.

Accordingly, the family of Javier del Ser Pérez is now interested in 19,203,115 Ordinary Shares, representing approximately 8.77% of the Company's existing issued share capital.

 

For further information, please contact:

Steppe Cement Limited

www.steppecement.com

Javier del Ser Pérez, Chief Executive Officer

Tel: +(603) 2166 0361

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

www.strandhanson.co.uk

James Spinney / Robert Collins / Ritchie Balmer

Tel: +44 20 7409 3494

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019.

PDMR Notification Form:

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Javier del Ser Pérez

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Steppe Cement Limited

b)

LEI

2138006TDVGH5T3U4Z46

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of nil par value each in the share capital of Steppe Cement Limited

Identification code

MYA004433001

b)

Nature of the Transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

13.42 pence

125,000

d)

Aggregated information

Aggregated volume Price

125,000 shares at 13.42 pence per share

e)

Date of the transaction

1 August 2024

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVLLBBZVLZBBF
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
27th May 20267:00 amRNSAnnual Financial Report
10th Apr 20267:00 amRNSTrading Update for the Quarter ended 31 March 2026
19th Jan 20268:03 amRNSInvestor Presentation via Investor Meet Company
15th Jan 20263:02 pmRNSReplacement - Trading Update
15th Jan 202610:45 amRNSTrading Update, Board Changes and Investment Plan
29th Dec 20257:00 amRNSCapital Repayment Payment Date
29th Dec 20257:00 amRNSCapital Repayment Payment Date
9th Dec 202510:30 amRNSCapital Repayment Record Date
5th Dec 20259:17 amRNSResult of EGM
14th Nov 20257:00 amRNSProposed Reduction & Repayment of Capital and EGM
17th Oct 20257:00 amRNSTrading Update for Q3 2025
15th Sep 20257:00 amRNSHalf-year Report
25th Jul 202511:07 amRNSResult of AGM
21st Jul 20251:34 pmRNSAGM – Submission of Shareholder Questions
7th Jul 20258:00 amRNSTrading Update
26th Jun 20257:55 amRNSNotice of AGM
26th Jun 20257:54 amRNSAnnual Financial Report
8th Apr 20258:29 amRNSTrading update for the quarter ended 31 March 2025
14th Jan 20257:00 amRNSYear End Trading Update
2nd Jan 202510:00 amRNSCapital Repayment Payment
12th Dec 20247:00 amRNSCapital Repayment Record Date
6th Dec 20248:39 amRNSResult of EGM
15th Nov 20247:00 amRNSProposed Reduction & Repayment of Capital and EGM
14th Oct 20247:00 amRNSTrading Update for Q3 2024
4th Oct 20249:15 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSHalf-year Report
6th Aug 20248:21 amRNSDirector's Dealing
2nd Aug 20249:44 amRNSDirector's Dealing
12th Jul 202410:08 amRNSResult of AGM and Market Update for H1 2024
4th Jul 20247:00 amRNSAGM - Submission of Shareholder Questions
19th Jun 20247:00 amRNSNotice of AGM
19th Jun 20247:00 amRNSAnnual Financial Report
23rd May 20247:00 amRNSCapital Repayment Record Date
26th Apr 20249:53 amRNSResult of EGM
9th Apr 20249:42 amRNSDirector's Dealing
5th Apr 20247:01 amRNSProposed Return of Cash to Shareholders and EGM
5th Apr 20247:00 amRNSTrading update for the quarter ended 31 March 2024
12th Jan 202410:15 amRNSYear End Trading Update
13th Dec 20239:15 amRNSUpdate re intention to pay a dividend
28th Nov 202311:44 amRNSDirector's Dealing
23rd Nov 20237:41 amRNSDirector's Dealing
11th Oct 20239:44 amRNSMarket Update for the Third Quarter September 2023
20th Sep 202310:19 amRNSDirector's Dealing
19th Sep 20239:00 amRNSHalf-year Report
13th Jul 20237:00 amRNSResult of AGM
12th Jul 20237:00 amRNSMarket Update - First half of 2023
4th Jul 20237:00 amRNSNotice of AGM and Submissions of Questions
9th Jun 20237:00 amRNSAnnual Financial Report
9th Jun 20237:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.